MEDICINOVA, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
MEDICINOVA, INC. (MNOV) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 8.32 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- MEDICINOVA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 8.32M shares, a 5.23% increase year-over-year.
- MEDICINOVA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 7.91M shares, a 3.42% decline year-over-year.
- MEDICINOVA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 7.90M shares, a 5.47% decline year-over-year.
- MEDICINOVA, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 7.91M shares, a 6.19% decline year-over-year.
- MEDICINOVA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 8.00M shares, a 13.66% increase from fiscal 2024.
- MEDICINOVA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 7.04M shares, a 9.52% decline from fiscal 2023.
- MEDICINOVA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 7.78M shares, a 2.55% decline from fiscal 2022.
- MEDICINOVA, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 7.99M shares, a 0.14% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 8.32M shares 10-Q · filed 2026-08-13 | 8.32M shares 10-Q · filed 2026-08-13 | |||||
| 2026-03-31 | 7.91M shares 10-Q · filed 2026-05-14 | ||||||
| 2025-12-31 | 8.00M shares 10-K · filed 2026-03-10 | ||||||
| 2025-09-30 | 7.90M shares 10-Q · filed 2025-11-12 | 7.90M shares 10-Q · filed 2025-11-12 | |||||
| 2025-06-30 | 7.91M shares 10-Q · filed 2026-08-13 | 7.91M shares 10-Q · filed 2026-08-13 | |||||
| 2025-03-31 | 8.19M shares 10-Q · filed 2026-05-14 | 7.91M shares 10-Q · filed 2025-05-13 | |||||
| 2024-12-31 | 7.04M shares 10-K · filed 2026-03-10 | ||||||
| 2024-09-30 | 8.36M shares 10-Q · filed 2025-11-12 | 8.36M shares 10-Q · filed 2025-11-12 | |||||
| 2024-06-30 | 8.43M shares 10-Q · filed 2025-08-14 | 8.43M shares 10-Q · filed 2025-08-14 | |||||
| 2024-03-31 | 8.58M shares 10-Q · filed 2025-05-13 | ||||||
| 2023-12-31 | 7.78M shares 10-K · filed 2025-02-19 | ||||||
| 2023-09-30 | 8.30M shares 10-Q · filed 2024-11-13 | 8.30M shares 10-Q · filed 2024-11-13 | |||||
| 2023-06-30 | 8.29M shares 10-Q · filed 2024-08-08 | 8.29M shares 10-Q · filed 2024-08-08 | |||||
| 2023-03-31 | 8.69M shares 10-Q · filed 2024-05-09 | ||||||
| 2022-12-31 | 7.99M shares 10-K · filed 2024-02-15 | ||||||
| 2022-09-30 | 7.99M shares 10-Q · filed 2023-11-09 | 7.99M shares 10-Q · filed 2023-11-09 | |||||
| 2022-06-30 | 8.01M shares 10-Q · filed 2023-08-09 | 8.01M shares 10-Q · filed 2023-08-09 | 8.22M shares 10-Q · filed 2022-08-11 | ||||
| 2022-03-31 | 7.97M shares 10-Q · filed 2023-05-11 | ||||||
| 2021-12-31 | 7.97M shares 10-K/A · filed 2023-03-28 | ||||||
| 2021-09-30 | 8.10M shares 10-Q · filed 2022-11-10 | 8.10M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 8.01M shares 10-Q · filed 2022-08-11 | 8.22M shares 10-Q · filed 2021-08-12 | 8.22M shares 10-Q · filed 2022-08-11 | ||||
| 2021-03-31 | 8.28M shares 10-Q · filed 2022-05-12 | ||||||
| 2020-12-31 | 7.40M shares 10-K · filed 2022-02-16 | ||||||
| 2020-09-30 | 7.51M shares 10-Q · filed 2021-11-12 | 7.51M shares 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | 7.61M shares 10-Q · filed 2021-08-12 | 7.61M shares 10-Q · filed 2021-08-12 | |||||
| 2020-03-31 | 7.64M shares 10-Q · filed 2021-05-13 | ||||||
| 2019-12-31 | 6.80M shares 10-K · filed 2021-02-19 | ||||||
| 2019-09-30 | 6.80M shares 10-Q · filed 2020-10-26 | 6.80M shares 10-Q · filed 2020-10-26 | |||||
| 2019-06-30 | 6.83M shares 10-Q · filed 2020-07-28 | ||||||
| 2019-03-31 | 6.80M shares 10-Q · filed 2020-04-23 | ||||||
| 2018-12-31 | 6.61M shares 10-K · filed 2020-02-13 | ||||||
| 2018-09-30 | 6.61M shares 10-Q · filed 2019-10-24 | ||||||
| 2018-06-30 | 6.61M shares 10-Q · filed 2019-07-25 | ||||||
| 2018-03-31 | 7.30M shares 10-Q · filed 2019-04-25 | ||||||
| 2017-12-31 | 6.26M shares 10-K · filed 2019-02-13 | ||||||
| 2017-09-30 | 6.42M shares 10-Q · filed 2018-10-25 | ||||||
| 2017-06-30 | 6.46M shares 10-Q · filed 2018-07-23 | ||||||
| 2017-03-31 | 6.62M shares 10-Q · filed 2018-04-25 | ||||||
| 2016-12-31 | 5.50M shares 10-K · filed 2019-02-13 | ||||||
| 2016-09-30 | 6.05M shares 10-Q · filed 2017-10-23 | ||||||
| 2016-06-30 | 6.14M shares 10-Q · filed 2017-07-26 | ||||||
| 2016-03-31 | 8.33M shares 10-Q · filed 2017-04-26 | ||||||
| 2015-12-31 | 9.74M shares 10-K · filed 2018-02-13 | ||||||
| 2015-09-30 | 9.74M shares 10-Q · filed 2016-10-25 | ||||||
| 2015-06-30 | 9.75M shares 10-Q · filed 2016-07-26 | ||||||
| 2015-03-31 | 9.96M shares 10-Q · filed 2016-04-27 | ||||||
| 2014-12-31 | 9.31M shares 10-K · filed 2017-02-14 | ||||||
| 2014-09-30 | 9.13M shares 10-Q · filed 2015-10-29 | ||||||
| 2014-06-30 | 9.14M shares 10-Q · filed 2015-07-30 | ||||||
| 2014-03-31 | 9.07M shares 10-Q · filed 2015-05-11 | ||||||
| 2013-12-31 | 9.18M shares 10-K · filed 2015-03-12 | ||||||
| 2013-09-30 | 8.98M shares 10-Q · filed 2014-11-13 | ||||||
| 2013-06-30 | 9.41M shares 10-Q · filed 2014-08-13 | ||||||
| 2013-03-31 | 8.54M shares 10-Q · filed 2014-05-08 | ||||||
| 2012-12-31 | 8.66M shares 10-K · filed 2014-03-27 | ||||||
| 2012-09-30 | 2.20M shares 10-Q · filed 2012-11-08 | 8.66M shares 10-Q · filed 2013-11-07 | 2.20M shares 10-Q · filed 2012-11-08 | ||||
| 2012-06-30 | 2.21M shares 10-Q · filed 2012-08-09 | 7.96M shares 10-Q · filed 2013-08-08 | 2.20M shares 10-Q · filed 2012-08-09 | ||||
| 2012-03-31 | 8.29M shares 10-Q · filed 2013-05-08 | ||||||
| 2011-12-31 | 8.29M shares 10-K · filed 2013-03-28 | ||||||
| 2011-09-30 | 22.86K shares 10-Q · filed 2012-11-08 | 130.73K shares 10-Q · filed 2012-11-08 | |||||
| 2011-06-30 | 29.40K shares 10-Q · filed 2012-08-09 | 73.99K shares 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |